SMAD2 and non-small cell lung carcinoma: The increased stability of LncRMRP due to m6A modification activates the SMAD2/SMAD3 pathway by enhancing TGFBR1 transcription, ultimately accelerating non-small cell lung cancer (NSCLC) progression42.